Filters

2019 - 201912020 - 20211

More filters

2020 - 20222
Reset filters

Settings

search.filters.applied.f.access: openAccess Ă— Author: Koch, Marcus Ă— DDC: 610 Ă— Type: Text Ă— Subject: Nanoparticles Ă— WGL Institute: INM Ă—

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Reliable release testing for nanoparticles with the NanoDis System, an innovative sample and separate technique
    (New York, NY [u.a.] : Elsevier, 2021) Lombardo, Sonia M.; TĂĽreli, Nazende GĂĽnday; Koch, Marcus; Schneider, Marc; TĂĽreli, Akif E.
    One of the critical quality attributes of nanoparticle formulations is drug release. Their release properties should therefore be well characterized with predictive and discriminative methods. However, there is presently still no standard method for the release testing of extended release nanoformulations. Dialysis techniques are widely used in the literature but suffer from severe drawbacks. Burst release of formulations can be masked by slow permeation kinetics of the free drug through the dialysis membrane, saturation in the membrane, and absence of agitation in the membrane. In this study, the release profile of poly(lactic co-glycolic) (PLGA) nanocapsules loaded with all-trans retinoic acid was characterized using an innovative sample and separate set-up, the NanoDis System, and compared to the release profile measured with a dialysis technique. The NanoDis System showed clear superiority over the dialysis method and was able to accurately characterize the burst release from the capsules and furthermore discriminate between different all-trans retinoic acid nanoparticle formulations.
  • Thumbnail Image
    Item
    The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB
    (London : BioMed Central, 2019) Formicola, Beatrice; Dal, Magro, Roberta; Montefusco-Pereira, Carlos V.; Lehr, Claus‑Michael; Koch, Marcus; Russo, Laura; Grasso, Gianvito; Deriu, Marco A.; Danani, Andrea; Bourdoulous, Sandrine; Re, Francesca
    We designed liposomes dually functionalized with ApoE-derived peptide (mApoE) and chlorotoxin (ClTx) to improve their blood-brain barrier (BBB) crossing. Our results demonstrated the synergistic activity of ClTx-mApoE in boosting doxorubicin-loaded liposomes across the BBB, keeping the anti-tumour activity of the drug loaded: mApoE acts promoting cellular uptake, while ClTx promotes exocytosis of liposomes. © 2019 The Author(s).